BAYLOR INSTITUTE FOR REHABILITATION
1. Target Overview & Investment Thesis
BAYLOR INSTITUTE FOR REHABILITATION is a 92-bed suburban community hospital in DALLAS, TX with $163.9M in net patient revenue and a -3.8% operating margin. The hospital serves a payer mix of 32.7% Medicare, 6.3% Medicaid, and 60.9% commercial.
Thesis: Turnaround. Our ML models identify $12.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.8% to 3.6% (+736bps).
| Net Revenue HCRIS | $163.9M |
| Current EBITDA COMPUTED | $-6.2M |
| Operating Margin COMPUTED | -3.8% |
| Occupancy HCRIS | 85.5% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 51.2% |
| Distress Probability ML | 42.2% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -3.8% places it below the state median. Among 198 size-comparable peers (46-184 beds), the median margin is 2.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (46-184), prioritizing same-state peers. 198 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BAYLOR INSTITUTE FOR REHABILIT (Target) | TX | 92 | $163.9M | -3.8% |
| ROUND ROCK HOSPITAL | TX | 165 | $681.4M | 8.7% |
| THE HEART HOSPITAL BAYLOR PLAN | TX | 109 | $464.6M | 25.7% |
| COVENANT CHILDRENS HOSPITAL | TX | 181 | $410.3M | 15.5% |
| COLLEGE STATION HOSPITAL | TX | 135 | $397.7M | -0.9% |
| CHILDRENS HOSPITAL OF SAN ANTO | TX | 174 | $376.5M | -2.8% |
| DECATUR COMMUNITY HOSPITAL | TX | 81 | $361.0M | -15.5% |
| CHILDRENS MEDICAL CENTER OF PL | TX | 72 | $336.7M | 20.9% |
| MEDICAL CITY MCKINNEY | TX | 166 | $302.5M | -0.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $105K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.2M |
| + RCM Uplift | +$12.1M |
| Pro Forma EBITDA | $5.9M |
| Current Margin | -3.8% |
| Pro Forma Margin | 3.6% |
| WC Released (1x) | $6.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-9.6M | $79.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-9.6M | $84.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-8.6M | $121.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-8.6M | $129.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-10.5M | $22.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-10.5M | $21.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 198 hospitals with 46-184 beds
- Same-state prioritization (n=199)
- Comp margins: P25=-10.8% / P50=2.7% / P75=11.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.